Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma

Authors

  • LV Gayosso-Gómez Research Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • G Zárraga-Granados Research Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • P Paredes-Garcia Research Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • R Falfán-Valencia Department of HLA, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • ME Vazquez-Manríquez Department of Pathology, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • LM Martinez-Barrera Pneumology-Oncology Service, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • P Castillo-Gonzalez Pneumology-Oncology Service, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • U Rumbo-Nava Pneumology-Oncology Service, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • R Guevara-Gutierrez Department of Clinical Analysis, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • B Rivera-Bravo Department of Nuclear Medicine, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • A Ramirez-Venegas COPD and Smoking Cessation Clinics, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • R Sansores COPD and Smoking Cessation Clinics, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • MC Negrete-Garcia Research Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
  • Blanca Ortiz-Quintero Research Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico

Keywords:

circulating miRNAs, malignant pleural mesothelioma, lung adenocarcinoma, differential diagnosis, non-invasive biomarkers

Abstract

Accurate diagnosis of malignant pleura mesothelioma (MPM) is challenging. Differential diagnosis of MPM versus lung adenocarcinoma (AD) is particularly difficult, yet clinically important since the two neoplasias call for different treatment approaches. Circulating miRNA-profiling to identify miRNAs that can be used to distinguish MPM from AD has not been reported.

We conducted a wide screening study of miRNA profiles in serum pools of MPM patients (N = 11), AD patients (N = 36), and healthy subjects (N = 45) to identify non-invasive biomarkers for differential diagnosis of MPM and AD, using deep sequencing.

Sequencing detected up to 300 known miRNAs and up to 25 novel miRNAs species in the serum samples. Among known miRNAs, 7 were upregulated in MPM and 12 were upregulated in AD compared to healthy controls. Of these, eight were distinctive for AD and three were unique for MPM. Direct comparison of the miRNA profiles for MPM and AD revealed differences in miRNA levels that could be useful for differential diagnosis. No differentially expressed novel miRNAs were found. Further bioinformatics analysis indicated that three upregulated miRNAs in MPM are associated with the p38 pathway.

There are unique alterations in serum miRNAs in MPM and AD compared to healthy controls, as well as differences between MPM and AD profiles. Differing miRNA levels between MPM and AD may be useful for differential diagnosis. A potential association to p38 pathway of three upregulated miRNAs in MPM was revealed.

Downloads

Published

2014-07-08

How to Cite

Gayosso-Gómez, L., Zárraga-Granados, G., Paredes-Garcia, P., Falfán-Valencia, R., Vazquez-Manríquez, M., Martinez-Barrera, L., … Ortiz-Quintero, B. (2014). Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma. EXCLI Journal, 13, 740–750. Retrieved from https://www.excli.de/index.php/excli/article/view/736

Issue

Vol. 13 (2014)

Section

Original articles

License

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).